Jin Qian

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 14, 2026
Author Correction: SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.

Bin Li, Ming-Chao Zhong, Cristian Camilo Galindo

|Feb 11, 2026
SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.

Bin Li, Ming-Chao Zhong, Cristian Camilo Galindo

|Oct 10, 2025
Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPα.

Zhenghai Tang, Ming-Chao Zhong, Jin Qian

|Sep 30, 2025
CD2 and its ligands are involved in development and activation of MAIT cells.

Kaiwen Zhu, Jiayu Dou, Bin Li

|Aug 05, 2022
Cis interactions between CD2 and its ligands on T cells are required for T cell activation.

Bin Li, Yan Lu, Ming-Chao Zhong

Pageof 1